ORF Biologics, Inc.

CIK 2048350 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ORF Biologics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 31, 2026D0002048350-26-000004
Dec 12, 2024D0002048350-24-000001